Literature DB >> 19606498

STAT1/IRF-1 signaling pathway mediates the injurious effect of interferon-gamma on oligodendrocyte progenitor cells.

Yan Wang1, Zhihua Ren, Duan Tao, Shilpa Tilwalli, Rajendra Goswami, Roumen Balabanov.   

Abstract

Interferon-gamma (IFN-gamma) is a pleiotropic cytokine that is critically involved in the pathogenesis of inflammatory demyelinating diseases. There is strong evidence that IFN-gamma can function as a distinct and independent injurious factor to oligodendrocyte progenitor cells (OPCs). The intracellular signaling pathways leading to OPC death, however, remain poorly understood. In this study, we examined IFN-gamma signaling in OPCs in relation to cell death in vitro. Using expression knock-down and forced overexpression methods, we directly demonstrated the role of signal transducer and transcription activator 1 (STAT1) and interferon-regulated factor 1 (IRF-1) in IFN-gamma- induced OPC death. In addition, our study identified two proapoptotic genes, caspase 1 and double-stranded RNA-dependent protein kinase (PKR), whose expression was upregulated by IFN-gamma and transcriptionally controlled by IRF-1. The conclusion of this study is that STAT1 and IRF-1 function as components of the signaling pathway that mediates IFN-gamma-induced OPC death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19606498     DOI: 10.1002/glia.20912

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  27 in total

1.  Interferon-γ inhibits central nervous system myelination through both STAT1-dependent and STAT1-independent pathways.

Authors:  Wensheng Lin; Yifeng Lin
Journal:  J Neurosci Res       Date:  2010-09       Impact factor: 4.164

2.  Central nervous system expression of interferon regulatory factor 1 regulates experimental autoimmune encephalomyelitis.

Authors:  Zhihua Ren; Yan Wang; Duan Tao; David Liebenson; Thomas Liggett; Rajendra Goswami; Dusan Stefoski; Roumen Balabanov
Journal:  J Neuroimmune Pharmacol       Date:  2010-02-23       Impact factor: 4.147

3.  Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors.

Authors:  Jing Wang; Darpan Saraswat; Anjali K Sinha; Jessie Polanco; Karen Dietz; Melanie A O'Bara; Suyog U Pol; Hani J Shayya; Fraser J Sim
Journal:  Cell Rep       Date:  2018-12-18       Impact factor: 9.423

4.  cFLIP is critical for oligodendrocyte protection from inflammation.

Authors:  D C Tanner; A Campbell; K M O'Banion; M Noble; M Mayer-Pröschel
Journal:  Cell Death Differ       Date:  2015-01-30       Impact factor: 15.828

Review 5.  Interferon regulatory factor signaling in autoimmune disease.

Authors:  Bharati Matta; Su Song; Dan Li; Betsy J Barnes
Journal:  Cytokine       Date:  2017-03-07       Impact factor: 3.861

6.  CXCR2 signaling protects oligodendrocyte progenitor cells from IFN-γ/CXCL10-mediated apoptosis.

Authors:  Emanuele Tirotta; Richard M Ransohoff; Thomas E Lane
Journal:  Glia       Date:  2011-06-08       Impact factor: 7.452

7.  Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis.

Authors:  Zhihua Ren; Yan Wang; Duan Tao; David Liebenson; Thomas Liggett; Rajendra Goswami; Robert Clarke; Dusan Stefoski; Roumen Balabanov
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

8.  Essential role for Mnk kinases in type II interferon (IFNgamma) signaling and its suppressive effects on normal hematopoiesis.

Authors:  Sonali Joshi; Bhumika Sharma; Surinder Kaur; Beata Majchrzak; Takeshi Ueda; Rikiro Fukunaga; Amit K Verma; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

9.  Cross-immunoreactivity between bacterial aquaporin-Z and human aquaporin-4: potential relevance to neuromyelitis optica.

Authors:  Zhihua Ren; Yan Wang; Tao Duan; Jilpa Patel; Thomas Liggett; Eileah Loda; Sarang Brahma; Rajendra Goswami; Carrie Grouse; Richard Byrne; Dusan Stefoski; Adil Javed; Stephen D Miller; Roumen Balabanov
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

Review 10.  Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.

Authors:  Brett S Marro; Caroline A Blanc; Jeanne F Loring; Michael D Cahalan; Thomas E Lane
Journal:  Expert Rev Neurother       Date:  2014-10       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.